Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
The Role of Toxin-Antitoxin Modules in Pseudomonas aeruginosa Phenotypic Heterogeneity and Antibiotic Tolerance
Third-party funded project
Project title The Role of Toxin-Antitoxin Modules in Pseudomonas aeruginosa Phenotypic Heterogeneity and Antibiotic Tolerance
Principal Investigator(s) Jenal, Urs
Organisation / Research unit Departement Biozentrum / Infection Biology,
Departement Biozentrum / Molecular Microbiology (Jenal)
Project start 01.10.2019
Probable end 30.09.2023
Status Completed
Abstract

Stochastic binary decisions generate phenotypic heterogeneity in bacterial populations, thereby contributing to bet-hedging processes and to division-of-labor. While specific bimodal programs were implicated in bacterial virulence 1 and antibiotic tolerance 2, the mechanisms leading to bi-nary cellular responses and the resulting consequences for population fitness and resilience are often unclear. Here, we aim at dissecting the role of two novel toxin-antitoxin (TA) modules in Pseudomonas aeruginosa, one of three human pathogens recently listed as critical-priority by the WHO. One of the hallmarks of bacterial TA systems is the binary expression of toxins or toxin-like factors, leading to the generation of functional heterogeneity in bacterial populations. We hypoth-esize that the TA modules PA1029-PA1030 and PA2780-PA2781 contribute to behavioral heteroge-neity and antibiotic tolerance of cultures of P. aeruginosa and by that contribute to the establish-ment of successful infections. To strengthen this idea, we propose to embark on a thorough func-tional examination of both modules.In the first part of the project, we plan to dissect the regulation and function of the toxin PA1030 and its antitoxin PA1029. Activating mutations in the PA1030 gene were originally identified in isolates of chronically infected CF patients and were shown to confer strongly increased tolerance against different classes of antibiotics. Our preliminary data suggest that stochastic expression of PA1030 generates persisters by modulating the cellular NAD pool. We propose a combination of biochemical, structural and cell biology experiments to determine the mechanisms of toxin action on the cells’ metabolism and its stochastic control. These experiments will test the central hypoth-esis that the PA1029-PA1030 TA module generates persisters upon sensing the depletion of a cen-tral metabolite. We will investigate the role of this TA module in chronic infections by characterizing TA variants from clinical isolates and by quantifying the expression of the TA components in pa-tient samples. In the second part of the project, we will dissect the TA-like module PA2780-PA2781, which through its stochastic expression generates behavioral diversity in P. aeruginosa cells colonizing surfaces to form biofilms. Biofilms are multicellular communities that strongly promote chronic infections by protecting pathogens from phagocytic clearance and safeguarding bacteria from an-tibiotic killing. Based on preliminary results, we hypothesize that PA2780-PA2781 converts regu-latory input from the global Gac/Rsm cascade into a binary cellular response, generating pheno-typic heterogeneity through the control of c-di-GMP-dependent processes like virulence, biofilm formation and persistence. We postulate that this system provides P. aeruginosa with a bet-hedging strategy to functionally diversify during infection and colonization of host tissues. Our studies will uncover the mechanisms of stochastic expression and downstream processes of this TA-like mod-ule and will investigate its role in P. aeruginosa virulence and persistence. 

Keywords Antibiotic tolerance, Toxin-antitoxin module, Pseudomonas aeruginosa, Biofilm formation, Phenotypic heterogeneity, stochastic binary gene expression, chronic infection
Financed by Swiss National Science Foundation (SNSF)

Cooperations ()

  ID Kreditinhaber Kooperationspartner Institution Laufzeit - von Laufzeit - bis
4639454  Jenal, Urs  Maier, Timm, Prof.  Biozentrum, Universität Basel  01.10.2019  30.09.2023 
4639455  Jenal, Urs  Egli, Adrian, Prof. Dr. med.  University Hospital Basel  01.10.2019  30.09.2023 
4639457  Jenal, Urs  Zamboni, Nicola, Prof.  Institute of Molecular Systems Biology, ETHZ  01.10.2019  30.09.2023 
   

MCSS v5.8 PRO. 0.407 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
13/05/2024